Announcement of the Advisory Panel on Outreach and Education (APOE) September 23, 2020 Virtual Meeting

Citation85 FR 52134
Record Number2020-18535
Published date24 August 2020
SectionNotices
CourtCenters For Medicare & Medicaid Services
Federal Register, Volume 85 Issue 164 (Monday, August 24, 2020)
[Federal Register Volume 85, Number 164 (Monday, August 24, 2020)]
                [Notices]
                [Pages 52134-52136]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2020-18535]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                Centers for Medicare & Medicaid Services
                [CMS-7059-N]
                Announcement of the Advisory Panel on Outreach and Education
                (APOE) September 23, 2020 Virtual Meeting
                AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: This notice announces the next meeting of the APOE (the Panel)
                in accordance with the Federal Advisory Committee Act. The Panel
                advises and makes recommendations to the Secretary of the U.S.
                Department of Health and Human Services (HHS) and the Administrator of
                the Centers for Medicare & Medicaid Services (CMS) on opportunities to
                enhance the effectiveness of consumer education strategies concerning
                the Health Insurance Marketplace[supreg], Medicare, Medicaid, and the
                Children's Health Insurance Program (CHIP). This meeting is open to the
                public.
                DATES:
                 Meeting Date: Wednesday, September 23, 2020 from 12:00 p.m. to 5:00
                p.m. eastern daylight time (e.d.t).
                 Deadline for Meeting Registration, Presentations, Special
                Accommodations and Comments: Wednesday, September 9, 2020, 5:00 p.m.
                (e.d.t).
                ADDRESSES:
                 Meeting Location: Virtual. All those who RSVP will receive the link
                to attend.
                 Presentations and Written Comments: Presentations and written
                comments should be submitted to: Lisa Carr, Designated Federal Official
                (DFO), Office of Communications, Centers for Medicare & Medicaid
                Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC
                20201, 202-690-5742, or via email at [email protected].
                 Registration: The meeting is open to the public, but attendance is
                limited to the space available. Persons wishing to attend this meeting
                must register at the website https://www.eventbrite.com/e/apoe-september-23-2020-virtual-meeting-tickets-114295017474 or by contacting
                the DFO listed in the FOR FURTHER INFORMATION CONTACT section of this
                notice, by the date listed in the DATES section of this notice.
                Individuals requiring sign language interpretation or other special
                accommodations should contact the DFO at the address listed in the
                ADDRESSES section of this notice by
                [[Page 52135]]
                the date listed in the DATES section of this notice.
                FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal
                Official, Office of Communications, 200 Independence Avenue SW,
                Mailstop 325G HHH, Washington, DC 20201, 202-690-5742, or via email at
                [email protected].
                 Additional information about the APOE is available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE. Press
                inquiries are handled through the CMS Press Office at (202) 690-6145.
                SUPPLEMENTARY INFORMATION:
                I. Background and Charter Renewal Information
                A. Background
                 The Advisory Panel for Outreach and Education (APOE) (the Panel) is
                governed by the provisions of the Federal Advisory Committee Act (FACA)
                (Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth
                standards for the formation and use of federal advisory committees. The
                Panel is authorized by section 1114(f) of the Social Security Act (42
                U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42
                U.S.C. 217a).
                 The Secretary of the U.S. Department of Health and Human Services
                (HHS) (the Secretary) signed the charter establishing the Citizen's
                Advisory Panel on Medicare Education \1\ (the predecessor to the APOE)
                on January 21, 1999 (64 FR 7899) to advise and make recommendations to
                the Secretary and the Administrator of the Centers for Medicare &
                Medicaid Services (CMS) on the effective implementation of national
                Medicare education programs, including with respect to the
                Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997
                (Pub. L. 105-33).
                ---------------------------------------------------------------------------
                 \1\ We note that the Citizen's Advisory Panel on Medicare
                Education is also referred to as the Advisory Panel on Medicare
                Education (65 FR 4617). The name was updated in the Second Amended
                Charter approved on July 24, 2000.
                ---------------------------------------------------------------------------
                 The Medicare Prescription Drug, Improvement, and Modernization Act
                of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan
                options and benefits available under the M+C program and renamed it the
                Medicare Advantage (MA) program. CMS has had substantial
                responsibilities to provide information to Medicare beneficiaries about
                the range of health plan options available and better tools to evaluate
                these options. The successful MA program implementation required CMS to
                consider the views and policy input from a variety of private sector
                constituents and to develop a broad range of public-private
                partnerships.
                 In addition, Title I of the MMA authorized the Secretary and the
                Administrator of CMS (by delegation) to establish the Medicare
                prescription drug benefit. The drug benefit allows beneficiaries to
                obtain qualified prescription drug coverage. In order to effectively
                administer the MA program and the Medicare prescription drug benefit,
                we have substantial responsibilities to provide information to Medicare
                beneficiaries about the range of health plan options and benefits
                available, and to develop better tools to evaluate these plans and
                benefits.
                 The Patient Protection and Affordable Care Act (Pub. L. 111-148)
                and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-
                152) (collectively referred to as the Affordable Care Act) expanded the
                availability of other options for healthcare coverage and enacted a
                number of changes to Medicare as well as to Medicaid and CHIP.
                Qualified individuals and qualified employers are now able to purchase
                private health insurance coverage through a competitive marketplace,
                called an Affordable Insurance Exchange (also called Health Insurance
                Marketplace[supreg], or Marketplace[supreg] \2\). In order to
                effectively implement and administer these changes, we must provide
                information to consumers, providers, and other stakeholders through
                education and outreach programs regarding how existing programs will
                change and the expanded range of health coverage options available,
                including private health insurance coverage through the
                Marketplace[supreg]. The APOE (the Panel) allows us to consider a broad
                range of views and information from interested audiences in connection
                with this effort and to identify opportunities to enhance the
                effectiveness of education strategies concerning the Affordable Care
                Act.
                ---------------------------------------------------------------------------
                 \2\ Health Insurance Marketplace[supreg]\SM\ and
                Marketplace[supreg]\SM\ are service marks of the U.S. Department of
                Health & Human Services.
                ---------------------------------------------------------------------------
                 The scope of this Panel also includes advising on issues pertaining
                to the education of providers and stakeholders with respect to the
                Affordable Care Act and certain provisions of the Health Information
                Technology for Economic and Clinical Health (HITECH) Act enacted as
                part of the American Recovery and Reinvestment Act of 2009 (ARRA) (Pub.
                L. 111-5).
                 On January 21, 2011, the Panel's charter was renewed and the Panel
                was renamed the Advisory Panel for Outreach and Education. The Panel's
                charter was most recently renewed on January 19, 2019, and will
                terminate on January 19, 2021 unless renewed by appropriate action.
                B. Charter Renewal
                 In accordance with the January 19, 2019, charter, the APOE will
                advise the HHS and CMS on developing and implementing education
                programs that support individuals who are enrolled in or eligible for
                Medicare, Medicaid, CHIP, or coverage available through the Health
                Insurance Marketplace[supreg] and other CMS programs. The scope of this
                Federal Advisory Committee Act (FACA) group also includes advising on
                education of providers and stakeholders with respect to healthcare
                reform and certain provisions of the HITECH Act enacted as part of the
                ARRA.
                 The charter will terminate on January 19, 2021, unless renewed by
                appropriate action. The APOE was chartered under 42 U.S.C. 217a,
                section 222 of the Public Health Service Act, as amended. The APOE is
                governed by provisions of Public Law 92-463, as amended (5 U.S.C.
                Appendix 2), which sets forth standards for the formation and use of
                advisory committees.
                 In accordance with the renewed charter, the APOE will advise the
                Secretary of Health and Human Services and the CMS Administrator
                concerning optimal strategies for the following:
                 Developing and implementing education and outreach
                programs for individuals enrolled in, or eligible for, Medicare,
                Medicaid, the CHIP, and coverage available through the Health Insurance
                Marketplace[supreg] and other CMS programs.
                 Enhancing the federal government's effectiveness in
                informing Medicare, Medicaid, CHIP, or the Health Insurance
                Marketplace[supreg] consumers, issuers, providers, and stakeholders,
                pursuant to education and outreach programs of issues regarding these
                programs, including the appropriate use of public-private partnerships
                to leverage the resources of the private sector in educating
                beneficiaries, providers, partners and stakeholders.
                 Expanding outreach to vulnerable and underserved
                communities, including racial and ethnic minorities, in the context of
                Medicare, Medicaid, the CHIP and the Health Insurance
                Marketplace[supreg] education programs, and other CMS programs as
                designated.
                 Assembling and sharing an information base of ``best
                practices'' for helping consumers evaluate health coverage options.
                 Building and leveraging existing community infrastructures
                for information, counseling, and assistance.
                [[Page 52136]]
                 Drawing the program link between outreach and education,
                promoting consumer understanding of health care coverage choices, and
                facilitating consumer selection/enrollment, which in turn support the
                overarching goal of improved access to quality care, including
                prevention services, envisioned under the Affordable Care Act.
                 The current members of the Panel as of February 28, 2020 are: E.
                Lorraine Bell, Chief Officer, Population Health, Catholic Charities
                USA; Nazleen Bharmal, Medical Director of Community Partnerships,
                Cleveland Clinic; Angie Boddie, Director of Health Programs, National
                Caucus and Center on Black Aging, Inc.; Julie Carter, Senior Federal
                Policy Associate, Medicare Rights Center; Scott Ferguson, Director of
                Care Transitions and Population Health, Mount Sinai St. Luke's
                Hospital; Leslie Fried, Senior Director, Center for Benefits Access,
                National Council on Aging; David Goldberg, President and CEO of Mon
                Health System; Jean-Venable Robertson Goode, Professor, Department of
                Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia
                Commonwealth University; Ted Henson, Director of Health Center
                Performance and Innovation, National Association of Community Health
                Centers; Joan Ilardo, Director of Research Initiatives, Michigan State
                University, College of Human Medicine; Cheri Lattimer, Executive
                Director, National Transitions of Care Coalition; Cori McMahon, Vice
                President, Tridiuum; Alan Meade, Director of Rehab Services, Holston
                Medical group; Michael Minor, National Director, H.O.P.E. HHS
                Partnership, National Baptist Convention USA, Incorporated; Jina
                Ragland, Associate State Director of Advocacy and Outreach, AARP
                Nebraska; Morgan Reed, Executive Director, Association for Competitive
                Technology; Margot Savoy, Chair, Department of Family and Community
                Medicine, Temple University Physicians; Congresswoman Allyson Schwartz,
                President and CEO, Better Medicare Alliance; and; Tia Whitaker,
                Statewide Director, Outreach and Enrollment, Pennsylvania Association
                of Community Health Centers.
                II. Provisions of This Notice
                 In accordance with section 10(a) of the FACA, this notice announces
                a meeting of the APOE. The agenda for the September 23, 2020 meeting
                will include the following:
                 Welcome and listening session with CMS leadership
                 Recap of the previous (June 25, 2020) meeting
                 CMS programs, initiatives, and priorities
                 An opportunity for public comment
                 Meeting summary, review of recommendations, and next steps
                 Individuals or organizations that wish to make a 5-minute oral
                presentation on an agenda topic should submit a written copy of the
                oral presentation to the DFO at the address listed in the ADDRESSES
                section of this notice by the date listed in the DATES section of this
                notice. The number of oral presentations may be limited by the time
                available. Individuals not wishing to make an oral presentation may
                submit written comments to the DFO at the address listed in the
                ADDRESSES section of this notice by the date listed in the DATES
                section of this notice.
                III. Meeting Participation
                 The meeting is open to the public, but attendance is limited to
                registered participants. Persons wishing to attend this meeting must
                register at the website https://www.eventbrite.com/e/apoe-september-23-2020-virtual-meeting-tickets-114295017474 or contact the DFO at the
                address or number listed in the FOR FURTHER INFORMATION CONTACT section
                of this notice by the date specified in the DATES section of this
                notice. This meeting will be held virtually. Individuals who are not
                registered in advance will be unable to attend the meeting.
                IV. Collection of Information
                 This document does not impose information collection requirements,
                that is, reporting, recordkeeping, or third-party disclosure
                requirements. Consequently, there is no need for review by the Office
                of Management and Budget under the authority of the Paperwork Reduction
                Act of 1995 (44 U.S.C. Chapter 35).
                 The Administrator of the Centers for Medicare & Medicaid Services
                (CMS), Seema Verma, having reviewed and approved this document,
                authorizes Lynette Wilson, who is the Federal Register Liaison, to
                electronically sign this document for purposes of publication in the
                Federal Register.
                 Authority: Sec. 1114(f) of the Social Security Act (42 U.S.C.
                1314(f)), sec. 222 of the Public Health Service Act (42 U.S.C.
                217a), and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a)
                and 41 CFR part 102-3).
                 Dated: August 17, 2020.
                Lynette Wilson,
                Federal Register Liaison, Department of Health and Human Services.
                [FR Doc. 2020-18535 Filed 8-21-20; 8:45 am]
                BILLING CODE 4120-01-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT